● Recruiting

Angiotensin Receptor Blockers in Aortic Stenosis

Condition: Aortic Stenosis · Aortic Valve Stenosis · Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

PhasePhase 4

Planned participants144

Who can joinAll sexes, 20 Years to 99 Years

Healthy volunteersNo

About this study

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

This description comes directly from the study's public registry record.

Talk to the study team

Marie-Annick Clavel, PhD · 418-656-8711 · Marie-Annick.Clavel@criucpq.ulaval.ca

Always discuss trial participation with your own doctor first.

Locations (2)

CRIUCPQ	Québec, Quebec, Canada	Recruiting
Odense University Hospital	Odense, Denmark	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04913870